Potential Association Between Darbepoetin Alfa Administration and Reduced Proteinuria in Real‐World Clinical Practice: A Post Hoc Analysis of the <scp>BRIGHTEN</scp> Study
DA administration was associated with reduced proteinuria in a dose-dependent manner, particularly in patients with DKD.
Authors
- Ichiei Narita (ORCID: https://orcid.org/0000-0001-7692-3096)
- Tatsuo Kagimura (ORCID: https://orcid.org/0000-0001-9856-1006)
- Shuma Hirashio (ORCID: https://orcid.org/0009-0003-3741-5672)
- Takao Masaki (ORCID: https://orcid.org/0000-0003-4271-9964)
Institutions
- Foundation for Biomedical Research (US)
- Hiroshima University Hospital (JP)
- Higashihiroshima Medical Center (JP)
- Foundation for Biomedical Research and Innovation (JP)
- Niigata University (JP)
Publication Details
- Journal
- Nephrology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1111/nep.70140
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00